메뉴 건너뛰기




Volumn 5, Issue , 2009, Pages 713-722

Cardiovascular disease in patients with chronic kidney disease

Author keywords

Cardiovascular risk factors; Chronic kidney disease; Diabetes; Hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE PLUS SIMVASTATIN; FETUIN A; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 18; LANTHANUM; LOOP DIURETIC AGENT; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PLACEBO; SEVELAMER;

EID: 74049098643     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (94)

References (66)
  • 1
    • 0001822934 scopus 로고    scopus 로고
    • Epidemiology of cardiac disease in dialysis patients
    • Sarnak MJ, Levey AS. Epidemiology of cardiac disease in dialysis patients. Seminars in Nephrology. 1999;12:69-76.
    • (1999) Seminars in Nephrology , vol.12 , pp. 69-76
    • Sarnak, M.J.1    Levey, A.S.2
  • 2
    • 0038124736 scopus 로고    scopus 로고
    • Cardiovascular complications in patients with chronic renal insufficiency and chronic kidney failure]
    • Tesar V. [Cardiovascular complications in patients with chronic renal insufficiency and chronic kidney failure]. Vnitr Lek. 2003;49(5):383-387.
    • (2003) Vnitr Lek , vol.49 , Issue.5 , pp. 383-387
    • Tesar, V.1
  • 3
    • 0031848747 scopus 로고    scopus 로고
    • Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients
    • Lindholm B, Wang T, Heimburger O, Bergstrom J. Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients. Nephrol Dial Transplant. 1998;13 Suppl 6:66-73.
    • (1998) Nephrol Dial Transplant , vol.13 , Issue.SUPPL. 6 , pp. 66-73
    • Lindholm, B.1    Wang, T.2    Heimburger, O.3    Bergstrom, J.4
  • 4
    • 19744368621 scopus 로고    scopus 로고
    • Identifying patients with chronic kidney disease from general practice computer records
    • de LS, Chan T, Stevens P, O'Donoghue D, Hague N, Dzregah B, et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract. 2005;22(3):234-241.
    • (2005) Fam Pract , vol.22 , Issue.3 , pp. 234-241
    • de, L.S.1    Chan, T.2    Stevens, P.3    O'Donoghue, D.4    Hague, N.5    Dzregah, B.6
  • 5
    • 46349111414 scopus 로고    scopus 로고
    • Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study)
    • Parikh NI, Hwang SJ, Larson MG, Levy D, Fox CS. Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol. 2008;102(1):47-53.
    • (2008) Am J Cardiol , vol.102 , Issue.1 , pp. 47-53
    • Parikh, N.I.1    Hwang, S.J.2    Larson, M.G.3    Levy, D.4    Fox, C.S.5
  • 6
    • 0029928215 scopus 로고    scopus 로고
    • Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
    • Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27(3):347-354.
    • (1996) Am J Kidney Dis , vol.27 , Issue.3 , pp. 347-354
    • Levin, A.1    Singer, J.2    Thompson, C.R.3    Ross, H.4    Lewis, M.5
  • 7
    • 1642413198 scopus 로고    scopus 로고
    • Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization
    • Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659-663.
    • (2004) Arch Intern Med , vol.164 , Issue.6 , pp. 659-663
    • Keith, D.S.1    Nichols, G.A.2    Gullion, C.M.3    Brown, J.B.4    Smith, D.H.5
  • 8
    • 26944476003 scopus 로고    scopus 로고
    • Beyond Framingham: Cardiovascular risk profiling in ESRD
    • McClellan WM, Chertow GM. Beyond Framingham: cardiovascular risk profiling in ESRD. J Am Soc Nephrol. 2005;16(6):1539-1541.
    • (2005) J Am Soc Nephrol , vol.16 , Issue.6 , pp. 1539-1541
    • McClellan, W.M.1    Chertow, G.M.2
  • 9
    • 0031737649 scopus 로고    scopus 로고
    • Malnutrition, cardiac disease, and mortality: An integrated point of view
    • Bergstrom J, Lindholm B. Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis. 1998;32(5):834-841.
    • (1998) Am J Kidney Dis , vol.32 , Issue.5 , pp. 834-841
    • Bergstrom, J.1    Lindholm, B.2
  • 10
    • 33947247891 scopus 로고    scopus 로고
    • de MR, Snijder MB, van der Sman-de Beer, Seidell JC, Boeschoten EW, Krediet RT, et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol. 2007;18(3):967-974.
    • de MR, Snijder MB, van der Sman-de Beer, Seidell JC, Boeschoten EW, Krediet RT, et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol. 2007;18(3):967-974.
  • 12
    • 0141789624 scopus 로고    scopus 로고
    • Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patientlevel meta-analysis
    • Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, De Jong PE, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patientlevel meta-analysis. Ann Intern Med. 2003;139(4):244-252.
    • (2003) Ann Intern Med , vol.139 , Issue.4 , pp. 244-252
    • Jafar, T.H.1    Stark, P.C.2    Schmid, C.H.3    Landa, M.4    Maschio, G.5    De Jong, P.E.6
  • 13
    • 4644278069 scopus 로고    scopus 로고
    • Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial
    • Fellstrom B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, et al. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. Kidney Int. 2004;66(4):1549-1555.
    • (2004) Kidney Int , vol.66 , Issue.4 , pp. 1549-1555
    • Fellstrom, B.1    Holdaas, H.2    Jardine, A.G.3    Holme, I.4    Nyberg, G.5    Fauchald, P.6
  • 14
    • 22844450094 scopus 로고    scopus 로고
    • Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation
    • Fellstrom B, Jardine AG, Soveri I, Cole E, Neumayer HH, Maes B, et al. Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. Am J Transplant. 2005;5(8):1986-1991.
    • (2005) Am J Transplant , vol.5 , Issue.8 , pp. 1986-1991
    • Fellstrom, B.1    Jardine, A.G.2    Soveri, I.3    Cole, E.4    Neumayer, H.H.5    Maes, B.6
  • 15
    • 22344458137 scopus 로고    scopus 로고
    • Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
    • Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353(3):238-248.
    • (2005) N Engl J Med , vol.353 , Issue.3 , pp. 238-248
    • Wanner, C.1    Krane, V.2    Marz, W.3    Olschewski, M.4    Mann, J.F.5    Ruf, G.6
  • 16
    • 0025357286 scopus 로고
    • Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin
    • Silberberg J, Racine N, Barre P, Sniderman AD. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol. 1990;6(1):1-4.
    • (1990) Can J Cardiol , vol.6 , Issue.1 , pp. 1-4
    • Silberberg, J.1    Racine, N.2    Barre, P.3    Sniderman, A.D.4
  • 17
    • 0032572913 scopus 로고    scopus 로고
    • The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    • Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339(9):584-590.
    • (1998) N Engl J Med , vol.339 , Issue.9 , pp. 584-590
    • Besarab, A.1    Bolton, W.K.2    Browne, J.K.3    Egrie, J.C.4    Nissenson, A.R.5    Okamoto, D.M.6
  • 18
    • 0030404906 scopus 로고    scopus 로고
    • Renal findings in patients with short-term type 2 diabetes
    • Keller CK, Bergis KH, Fliser D, Ritz E. Renal findings in patients with short-term type 2 diabetes. J Am Soc Nephrol. 1996;7(12):2627-2635.
    • (1996) J Am Soc Nephrol , vol.7 , Issue.12 , pp. 2627-2635
    • Keller, C.K.1    Bergis, K.H.2    Fliser, D.3    Ritz, E.4
  • 20
    • 34548420712 scopus 로고    scopus 로고
    • Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial
    • Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370(9590):829-840.
    • (2007) Lancet , vol.370 , Issue.9590 , pp. 829-840
    • Patel, A.1    MacMahon, S.2    Chalmers, J.3    Neal, B.4    Woodward, M.5    Billot, L.6
  • 21
    • 34249899918 scopus 로고    scopus 로고
    • Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes
    • Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, et al. Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes. Diabetes Care. 2007;30(6):1577-1578.
    • (2007) Diabetes Care , vol.30 , Issue.6 , pp. 1577-1578
    • Makino, H.1    Haneda, M.2    Babazono, T.3    Moriya, T.4    Ito, S.5    Iwamoto, Y.6
  • 22
    • 0035922444 scopus 로고    scopus 로고
    • The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
    • Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345(12):870-878.
    • (2001) N Engl J Med , vol.345 , Issue.12 , pp. 870-878
    • Parving, H.H.1    Lehnert, H.2    Brochner-Mortensen, J.3    Gomis, R.4    Andersen, S.5    Arner, P.6
  • 23
    • 0035922441 scopus 로고    scopus 로고
    • Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    • Brenner BM, Cooper ME, de ZD, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861-869.
    • (2001) N Engl J Med , vol.345 , Issue.12 , pp. 861-869
    • Brenner, B.M.1    Cooper2    ME, D.Z.3    Keane, W.F.4    Mitch, W.E.5    Parving, H.H.6
  • 24
    • 0035922447 scopus 로고    scopus 로고
    • Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
    • Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851-860.
    • (2001) N Engl J Med , vol.345 , Issue.12 , pp. 851-860
    • Lewis, E.J.1    Hunsicker, L.G.2    Clarke, W.R.3    Berl, T.4    Pohl, M.A.5    Lewis, J.B.6
  • 25
    • 27744542905 scopus 로고    scopus 로고
    • Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial
    • Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, et al. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol. 2005;16(7):2170-2179.
    • (2005) J Am Soc Nephrol , vol.16 , Issue.7 , pp. 2170-2179
    • Berl, T.1    Hunsicker, L.G.2    Lewis, J.B.3    Pfeffer, M.A.4    Porush, J.G.5    Rouleau, J.L.6
  • 26
    • 0043201187 scopus 로고    scopus 로고
    • The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes]
    • Gaede PH, Jepsen PV, Larsen JN, Jensen GV, Parving HH, Pedersen OB. [The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes]. Ugeskr Laeger. 2003;165(26):2658-2661.
    • (2003) Ugeskr Laeger , vol.165 , Issue.26 , pp. 2658-2661
    • Gaede, P.H.1    Jepsen, P.V.2    Larsen, J.N.3    Jensen, G.V.4    Parving, H.H.5    Pedersen, O.B.6
  • 27
    • 0030893720 scopus 로고    scopus 로고
    • Renal function in the elderly: Impact of hypertension and cardiac function
    • Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int. 1997;51(4):1196-1204.
    • (1997) Kidney Int , vol.51 , Issue.4 , pp. 1196-1204
    • Fliser, D.1    Franek, E.2    Joest, M.3    Block, S.4    Mutschler, E.5    Ritz, E.6
  • 28
    • 0030666411 scopus 로고    scopus 로고
    • An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability
    • Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P. An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant. 1997;12(11):2301-2307.
    • (1997) Nephrol Dial Transplant , vol.12 , Issue.11 , pp. 2301-2307
    • Farmer, C.K.1    Goldsmith, D.J.2    Cox, J.3    Dallyn, P.4    Kingswood, J.C.5    Sharpstone, P.6
  • 29
    • 0030604561 scopus 로고    scopus 로고
    • Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia, Lancet. 1997;349(9069):1857-1863
    • Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet. 1997;349(9069):1857-1863.
  • 30
    • 0024370790 scopus 로고
    • Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group
    • Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension. 1989;13(5 Suppl):I80-I93.
    • (1989) Hypertension , vol.13 , Issue.5 SUPPL.
    • Shulman, N.B.1    Ford, C.E.2    Hall, W.D.3    Blaufox, M.D.4    Simon, D.5    Langford, H.G.6
  • 32
    • 0027231424 scopus 로고
    • Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure
    • Hannedouche T, Albouze G, Chauveau P, Lacour B, Jungers P. Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. Am J Kidney Dis. 1993;21(5 Suppl 2):131-137.
    • (1993) Am J Kidney Dis , vol.21 , Issue.5 SUPPL. 2 , pp. 131-137
    • Hannedouche, T.1    Albouze, G.2    Chauveau, P.3    Lacour, B.4    Jungers, P.5
  • 34
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group
    • Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351(9118):1755-1762.
    • (1998) Lancet , vol.351 , Issue.9118 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlof, B.4    Elmfeldt, D.5    Julius, S.6
  • 35
    • 0042885985 scopus 로고    scopus 로고
    • Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality
    • London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731-1740.
    • (2003) Nephrol Dial Transplant , vol.18 , Issue.9 , pp. 1731-1740
    • London, G.M.1    Guerin, A.P.2    Marchais, S.J.3    Metivier, F.4    Pannier, B.5    Adda, H.6
  • 36
    • 0029817038 scopus 로고    scopus 로고
    • Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus
    • Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16(8):978-983.
    • (1996) Arterioscler Thromb Vasc Biol , vol.16 , Issue.8 , pp. 978-983
    • Lehto, S.1    Niskanen, L.2    Suhonen, M.3    Ronnemaa, T.4    Laakso, M.5
  • 38
    • 1942485985 scopus 로고    scopus 로고
    • Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis
    • Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol. 2004;8(1):54-58.
    • (2004) Clin Exp Nephrol , vol.8 , Issue.1 , pp. 54-58
    • Matsuoka, M.1    Iseki, K.2    Tamashiro, M.3    Fujimoto, N.4    Higa, N.5    Touma, T.6
  • 39
    • 17144426995 scopus 로고    scopus 로고
    • Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients
    • Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, et al. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant. 2005;20(4):760-767.
    • (2005) Nephrol Dial Transplant , vol.20 , Issue.4 , pp. 760-767
    • Yildiz, A.1    Memisoglu, E.2    Oflaz, H.3    Yazici, H.4    Pusuroglu, H.5    Akkaya, V.6
  • 40
    • 0037216095 scopus 로고    scopus 로고
    • Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study
    • Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003;14(1):159-168.
    • (2003) J Am Soc Nephrol , vol.14 , Issue.1 , pp. 159-168
    • Wang, A.Y.1    Wang, M.2    Woo, J.3    Lam, C.W.4    Li, P.K.5    Lui, S.F.6
  • 41
    • 0027367239 scopus 로고
    • Osteopontin is elevated during neointima formation in rat arteries and is a novel component of artherosclerotic plaques
    • Giachelli CM, Bae N, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of artherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
    • (1993) J Clin Invest , vol.92 , pp. 1686-1696
    • Giachelli, C.M.1    Bae, N.2    Denhardt, D.T.3    Alpers, C.E.4    Schwartz, S.M.5
  • 42
    • 9644298257 scopus 로고    scopus 로고
    • Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro
    • Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int. 2004;66(6):2293-2299.
    • (2004) Kidney Int , vol.66 , Issue.6 , pp. 2293-2299
    • Yang, H.1    Curinga, G.2    Giachelli, C.M.3
  • 43
    • 0030008101 scopus 로고    scopus 로고
    • Electron beam computer tomography in the evaluation of cardiac calcification in chronic dialysis patients
    • Braun J, Oldendorf M, Moshage W. Electron beam computer tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;27:394-401.
    • (1996) Am J Kidney Dis , vol.27 , pp. 394-401
    • Braun, J.1    Oldendorf, M.2    Moshage, W.3
  • 44
    • 0027496973 scopus 로고
    • Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease
    • Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EB, Freemont TJ, et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int. 1993;44(5):1071-1077.
    • (1993) Kidney Int , vol.44 , Issue.5 , pp. 1071-1077
    • Hutchison, A.J.1    Whitehouse, R.W.2    Boulton, H.F.3    Adams, J.E.4    Mawer, E.B.5    Freemont, T.J.6
  • 45
    • 31644446801 scopus 로고    scopus 로고
    • Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
    • Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68(4):1815-1824.
    • (2005) Kidney Int , vol.68 , Issue.4 , pp. 1815-1824
    • Block, G.A.1    Spiegel, D.M.2    Ehrlich, J.3    Mehta, R.4    Lindbergh, J.5    Dreisbach, A.6
  • 46
    • 35349004713 scopus 로고    scopus 로고
    • Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
    • Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int. 2007;72(9):1130-1137.
    • (2007) Kidney Int , vol.72 , Issue.9 , pp. 1130-1137
    • Suki, W.N.1    Zabaneh, R.2    Cangiano, J.L.3    Reed, J.4    Fischer, D.5    Garrett, L.6
  • 47
    • 20844432154 scopus 로고    scopus 로고
    • Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)
    • Moe SM, Reslerova M, Ketteler M, O'Neill K, Duan D, Koczman J, et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int. 2005;67(6):2295-2304.
    • (2005) Kidney Int , vol.67 , Issue.6 , pp. 2295-2304
    • Moe, S.M.1    Reslerova, M.2    Ketteler, M.3    O'Neill, K.4    Duan, D.5    Koczman, J.6
  • 48
    • 0042073223 scopus 로고    scopus 로고
    • Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis
    • Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial. 2003;16(2):101-105.
    • (2003) Semin Dial , vol.16 , Issue.2 , pp. 101-105
    • Levin, A.1
  • 49
    • 0030847042 scopus 로고    scopus 로고
    • Cardiac disease in chronic uremia: Pathogenesis
    • London GM, Parfrey PS. Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther. 1997;4(3):194-211.
    • (1997) Adv Ren Replace Ther , vol.4 , Issue.3 , pp. 194-211
    • London, G.M.1    Parfrey, P.S.2
  • 50
    • 0028939185 scopus 로고
    • Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
    • Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47(1):186-192.
    • (1995) Kidney Int , vol.47 , Issue.1 , pp. 186-192
    • Foley, R.N.1    Parfrey, P.S.2    Harnett, J.D.3    Kent, G.M.4    Martin, C.J.5    Murray, D.C.6
  • 51
    • 33646688887 scopus 로고    scopus 로고
    • Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging
    • Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int. 2006;69(10):1839-1845.
    • (2006) Kidney Int , vol.69 , Issue.10 , pp. 1839-1845
    • Mark, P.B.1    Johnston, N.2    Groenning, B.A.3    Foster, J.E.4    Blyth, K.G.5    Martin, T.N.6
  • 52
    • 0025906705 scopus 로고
    • Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: A prospective study
    • Pascual J, Teruel JL, Moya JL, Liano F, Jimenez-Mena M, Ortuno J. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol. 1991;35(6):280-287.
    • (1991) Clin Nephrol , vol.35 , Issue.6 , pp. 280-287
    • Pascual, J.1    Teruel, J.L.2    Moya, J.L.3    Liano, F.4    Jimenez-Mena, M.5    Ortuno, J.6
  • 53
    • 0033159126 scopus 로고    scopus 로고
    • AT1-receptor blockers in hypertension and heart failure: Clinical experience and future directions
    • Willenheimer R, Dahlof B, Rydberg E, Erhardt L. AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions. Eur Heart J. 1999;20(14):997-1008.
    • (1999) Eur Heart J , vol.20 , Issue.14 , pp. 997-1008
    • Willenheimer, R.1    Dahlof, B.2    Rydberg, E.3    Erhardt, L.4
  • 54
    • 0028625446 scopus 로고
    • DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy
    • Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994;90(6):2622-2628.
    • (1994) Circulation , vol.90 , Issue.6 , pp. 2622-2628
    • Iwai, N.1    Ohmichi, N.2    Nakamura, Y.3    Kinoshita, M.4
  • 55
    • 0031443817 scopus 로고    scopus 로고
    • The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk
    • Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens. 1997;15(12 Pt 2):1579-1592.
    • (1997) J Hypertens , vol.15 , Issue.12 PART 2 , pp. 1579-1592
    • Staessen, J.A.1    Wang, J.G.2    Ginocchio, G.3    Petrov, V.4    Saavedra, A.P.5    Soubrier, F.6
  • 56
    • 0029907529 scopus 로고    scopus 로고
    • The role of genetic polymorphisms of angiotensinconverting enzyme in the progression of renal diseases
    • Mclaughlin KJ, Harden PN, Ueda S, Boulton-Jones JM, Connell JM, Jardine AG. The role of genetic polymorphisms of angiotensinconverting enzyme in the progression of renal diseases. Hypertension. 1996;28(5):912-915.
    • (1996) Hypertension , vol.28 , Issue.5 , pp. 912-915
    • Mclaughlin, K.J.1    Harden, P.N.2    Ueda, S.3    Boulton-Jones, J.M.4    Connell, J.M.5    Jardine, A.G.6
  • 57
    • 0036898135 scopus 로고    scopus 로고
    • Polymorphism of renin-angiotensin system genes in dialysis patients - association with cerebrovascular disease
    • Losito A, Kalidas K, Santoni S, Ceccarelli L, Jeffery S. Polymorphism of renin-angiotensin system genes in dialysis patients - association with cerebrovascular disease. Nephrol Dial Transplant. 2002;17(12):2184-2188.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.12 , pp. 2184-2188
    • Losito, A.1    Kalidas, K.2    Santoni, S.3    Ceccarelli, L.4    Jeffery, S.5
  • 59
    • 42549104621 scopus 로고    scopus 로고
    • Urinary IL-18 and NGAL as Early Predictive Biomarkers in Contrast-Induced Nephropathy after Coronary Angiography
    • Ling W, Zhaohui N, Ben H, Leyi G, Jianping L, Huili D, et al. Urinary IL-18 and NGAL as Early Predictive Biomarkers in Contrast-Induced Nephropathy after Coronary Angiography. Nephron Clin Pract. 2008;108(3):c176-c181.
    • (2008) Nephron Clin Pract , vol.108 , Issue.3
    • Ling, W.1    Zhaohui, N.2    Ben, H.3    Leyi, G.4    Jianping, L.5    Huili, D.6
  • 60
    • 0042410539 scopus 로고    scopus 로고
    • Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme
    • Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362(9386):759- 766.
    • (2003) Lancet , vol.362 , Issue.9386 , pp. 759-766
    • Pfeffer, M.A.1    Swedberg, K.2    Granger, C.B.3    Held, P.4    McMurray, J.J.5    Michelson, E.L.6
  • 61
    • 0035818884 scopus 로고    scopus 로고
    • A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    • Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345(23):1667-1675.
    • (2001) N Engl J Med , vol.345 , Issue.23 , pp. 1667-1675
    • Cohn, J.N.1    Tognoni, G.2
  • 63
    • 0034627208 scopus 로고    scopus 로고
    • Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
    • Mogensen CE, Neldam S, Tikkanen I, Oren S, Viskoper R, Watts RW, et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ. 2000;321(7274):1440-1444.
    • (2000) BMJ , vol.321 , Issue.7274 , pp. 1440-1444
    • Mogensen, C.E.1    Neldam, S.2    Tikkanen, I.3    Oren, S.4    Viskoper, R.5    Watts, R.W.6
  • 64
    • 49149087718 scopus 로고    scopus 로고
    • Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial
    • Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008;372(9638):547-553.
    • (2008) Lancet , vol.372 , Issue.9638 , pp. 547-553
    • Mann, J.F.1    Schmieder, R.E.2    McQueen, M.3    Dyal, L.4    Schumacher, H.5    Pogue, J.6
  • 66
    • 33847292348 scopus 로고    scopus 로고
    • Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease
    • Bergeron S, Hillis GS, Haugen EN, Oh JK, Bailey KR, Pellikka PA. Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J. 2007;153(3):385-391.
    • (2007) Am Heart J , vol.153 , Issue.3 , pp. 385-391
    • Bergeron, S.1    Hillis, G.S.2    Haugen, E.N.3    Oh, J.K.4    Bailey, K.R.5    Pellikka, P.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.